CVH metrics | Total sample (n = 5026) | Men (n = 2150) | Women (n = 2876) | p-valuea | |
---|---|---|---|---|---|
Smoking status, n (%) | Poor | 1045 (20.8) | 1006 (46.8) | 39 (1.4) | < 0.001 |
Intermediate | 355 (7.1) | 344 (16.0) | 11 (0.4) | Â | |
Ideal | 3626 (72.1) | 800 (37.2) | 2826 (98.3) | Â | |
Physical activity, n (%) | Poor | 1774 (35.3) | 708 (32.9) | 1066 (37.1) | < 0.001 |
Intermediate | 612 (12.2) | 222 (10.3) | 390 (13.6) | Â | |
Ideal | 2640 (52.5) | 1220 (56.7) | 1420 (49.4) | Â | |
Body mass index, n (%) | Poor | 974 (19.4) | 341 (15.9) | 633 (22.0) | < 0.001 |
Intermediate | 1920 (38.2) | 792 (36.8) | 1128 (39.2) | Â | |
Ideal | 2132 (42.4) | 1017 (47.3) | 1115 (38.8) | Â | |
Blood pressure, n (%) | Poor | 3148 (62.6) | 1295 (60.2) | 1853 (64.4) | 0.008 |
Intermediate | 1481 (29.5) | 668 (31.1) | 813 (28.3) | Â | |
Ideal | 397 (7.9) | 187 (8.7) | 210 (7.3) | Â | |
Total cholesterol, n (%) | Poor | 513 (10.2) | 100 (4.7) | 413 (14.4) | < 0.001 |
Intermediate | 1537 (30.6) | 525 (24.4) | 1012 (35.2) | Â | |
Ideal | 2976 (59.2) | 1525 (70.9) | 1451 (50.5) | Â | |
Fasting blood glucose, n (%) | Poor | 437 (8.7) | 168 (7.8) | 269 (9.4) | 0.032 |
Intermediate | 1151 (22.9) | 471 (21.9) | 680 (23.6) | Â | |
Ideal | 3438 (68.4) | 1511 (70.3) | 1927 (67.0) | Â | |
Global CVH metrics, n (%) | Poor | 1598 (31.8) | 760 (35.3) | 838 (29.1) | < 0.001 |
Intermediate | 2982 (59.3) | 1222 (56.8) | 1760 (61.2) | Â | |
Ideal | 446 (8.9) | 168 (7.8) | 278 (9.7) | Â | |
Behavioral CVH metrics, n (%) | Poor | 2087 (41.5) | 1186 (55.2) | 901 (31.3) | < 0.001 |
Intermediate | 2208 (43.9) | 760 (35.3) | 1448 (50.3) | Â | |
Ideal | 731 (14.5) | 204 (9.5) | 527 (18.3) | Â | |
Biological CVH metrics, n (%) | Poor | 2740 (54.5) | 975 (45.3) | 1765 (61.4) | < 0.001 |
Intermediate | 2069 (41.2) | 1058 (49.2) | 1011 (35.2) | Â | |
Ideal | 217 (4.3) | 117 (5.4) | 100 (3.5) | Â |